Research published today (Jan. 22) in the journal Brain reveals a new approach to Alzheimer’s disease (AD) that may eventually make it possible to reverse memory loss, a hallmark of the disease in its late stages.
The team, led by University at Buffalo scientists, found that by focusing on gene changes caused by influences other than DNA sequences — called epigenetics — it was possible to reverse memory decline in an animal model of AD.
“In this paper, we have not only identified the epigenetic factors that contribute to the memory loss, we also found ways to temporarily reverse them in an animal model of AD,” said senior author Zhen Yan, PhD, a SUNY Distinguished Professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB.
The research was conducted on mouse models carrying gene mutations for familial AD — where more than one member of a family has the disease — and on post-mortem brain tissues from AD patients.
AD is linked to epigenetic abnormality
AD results from both genetic and environmental risk factors, such as aging, which combine to result in epigenetic changes, leading to gene expression changes, but little is known about how that occurs.
The epigenetic changes in AD happen primarily in the later stages, when patients are unable to retain recently learned information and exhibit the most dramatic cognitive decline, Yan said. A key reason for the cognitive decline is the loss of glutamate receptors, which are critical to learning and short-term memory.
“We found that in Alzheimer’s disease, many subunits of glutamate receptors in the frontal cortex are downregulated, disrupting the excitatory signals, which impairs working memory,” Yan said.
The researchers found that the loss of glutamate receptors is the result of an epigenetic process known as repressive histone modification, which is elevated in AD. They saw this both in the animal models they studied and in post-mortem tissue of AD patients.
Yan explained that histone modifiers change the structure of chromatin, which controls how genetic material gains access to a cell’s transcriptional machinery.
“This AD-linked abnormal histone modification is what represses gene expression, diminishing glutamate receptors, which leads to loss of synaptic function and memory deficits,” Yan said.
Potential drug targets
Understanding that process has revealed potential drug targets, she said, since repressive histone modification is controlled or catalyzed by enzymes.
“Our study not only reveals the correlation between epigenetic changes and AD, we also found we can correct the cognitive dysfunction by targeting the epigenetic enzymes to restore glutamate receptors,” Yan said.
The AD animals were injected three times with compounds designed to inhibit the enzyme that controls repressive histone modification.
“When we gave the AD animals this enzyme inhibitor, we saw the rescue of cognitive function confirmed through evaluations of recognition memory, spatial memory and working memory. We were quite surprised to see such dramatic cognitive improvement,” Yan said.
“At the same time, we saw the recovery of glutamate receptor expression and function in the frontal cortex.”
The improvements lasted for one week; future studies will focus on developing compounds that penetrate the brain more effectively and are thus longer-lasting.
Brain disorders, such as AD, are often polygenetic diseases, Yan explained, where many genes are involved and each gene has a modest impact. An epigenetic approach is advantageous, she said, because epigenetic processes control not just one gene but many genes.
“An epigenetic approach can correct a network of genes, which will collectively restore cells to their normal state and restore the complex brain function,” she explained.
“We have provided evidence showing that abnormal epigenetic regulation of glutamate receptor expression and function did contribute to cognitive decline in Alzheimer’s disease,” Yan concluded. “If many of the dysregulated genes in AD are normalized by targeting specific epigenetic enzymes, it will be possible to restore cognitive function and behavior.”
The Latest on: Epigenetics
via Google News
The Latest on: Epigenetics
- Epigenetics Market Growing and Future Trend by 2029 | Illumina Inc, Merck & Co. Ltd., and Qiagenon November 13, 2019 at 9:04 pm
Nov 14, 2019 (WiredRelease via COMTEX) -- A Precise market analysis on Global Epigenetics Product Market | Know Up Trends And More About Industry Tycoons, Emerging Growth Factors, Opportunities, Top ...
- How to Use CRISPR for Site-Specific Epigenetic Editing in the Nervous Systemon November 13, 2019 at 1:32 pm
Roughly five years ago, when setting up his lab to study the epigenetics of addiction and memory at The University of Alabama at Birmingham, Jeremy J. Day, PhD, bet the house on CRISPR technologies ...
- Leukemia type B cell can transform into a macrophage through epigenetic changeson November 13, 2019 at 9:49 am
What gives cells their own identity and differentiates them is their particular epigenetics, the chemical modifications that control gene expression. It has been accepted for decades that the ...
- Constellation Pharmaceuticals to Participate in Upcoming Investor Conferenceson November 13, 2019 at 5:00 am
CAMBRIDGE, Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and ...
- VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Updateon November 12, 2019 at 12:10 pm
We are an epigenetics company focused on advancing the science of epigenetics and exploiting these advances in human and animal health. This has been our mission since our founding, and it is coming ...
- Epigenetics Industry Outlook, 2025on November 11, 2019 at 4:25 pm
Dublin, Nov. 11, 2019 (GLOBE NEWSWIRE) -- The "Global Epigenetics Market, By Product, Application, Technology, By Region, Growth Potential, Trends Analysis, Competitive Market Size and Forecast, ...
- Essential Science: Secret to living longer is more ‘rest’on November 10, 2019 at 7:05 pm
The research focus is with epigenetics. Scientists mapped changes in gene expression in people who died between 60 and 100 years old. The purpose was to understand how changes in gene expression ...
- ‘Watchmen’ episode four: ‘If You Don’t Like My Story Write Your Own’on November 10, 2019 at 7:00 pm
HBO’s Watchmen has now dumped epigenetics — the study of how genes are altered because of a person’s exposure to trauma, and how those alterations get passed down through multiple ...
- Australian Researchers Say Botswana is Ancestral Home of Modern Humanson November 9, 2019 at 12:56 pm
Vanessa M. Hayes, of the Genomics and Epigenetics Division of the Garvan Institute of Medical Research, and her colleagues said they used the mitochondrial DNA, which is passed down exclusively from ...
- A new understanding of aggressive cancer growth is identified; Top cancer research journal publishes The Hormel Institute researchon November 8, 2019 at 3:03 am
The results of a study led by Dr. Shujun Liu, head of the Cancer Epigenetics and Experimental Therapeutics lab at The Hormel Institute, were published in the high impact journal Nature Communications ...
via Bing News